ORAL ZINC SULFATE AS ADJUVANT TREATMENT IN CHILDREN WITH NEPHROLITHIASIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

YOUSEFICHAIJAN PARSA; CYRUS ALI; DORREH FATEMEH; RAFEIE MOHAMMAD; SHARAFKHAH MOJTABA; FROHAR FARYAR; SAFI FATEMEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pediatrics Year:2015 | Volume:25 | Issue:6 Page(s): 0-0

Download Full-Text

View:

352

Download:

212

Cites:

Information Journal Paper

Title

ORAL ZINC SULFATE AS ADJUVANT TREATMENT IN CHILDREN WITH NEPHROLITHIASIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL

Author(s)

Keywords

NEPHROLITHIASIS

ZINC SULFATE

CHILDREN

Abstract

Background: NEPHROLITHIASIS in CHILDREN is associated with a high rate of complications and recurrence.Objectives: Since some evidences reported that zinc has an important place amongst inhibitors of crystallization and crystal growth, we decided to assess the effectiveness of oral ZINC SULFATE as adjuvant treatment in CHILDREN with NEPHROLITHIASIS.Patients and Methods: This was a randomized, double-blind, placebo-controlled clinical trial. 102 CHILDREN in the age range 1 month to 11 years with first NEPHROLITHIASIS were recruited. Patients were randomly divided into two equal groups (intervention and control groups). Intervention group received conservative measures for stones and 1 mg/kg/day (maximum 20 mg/day) oral ZINC SULFATE syrup for 3 months. Control group received placebo in addition to conservative measures, also for 3 months. Patients were followed up by ultrasonography for 9 months, in 5 steps (at the end of 1st, 2nd, 3rd, 6th and 9th month after treatment) assessing size and number of stones in the kidneys.Results: Only at the end of the first month, the average number (intervention: 1.15±3.78, control: 1.3±2.84) (P=0.001) and size (cm) (intervention: 0.51±1.76, control: 0.62±1.39) (P=0.001) of stones was significantly lower in the intervention group, and in other points there was no significant therapeutic efficacy in oral zinc adjuvant treatment compared to conservative treatment alone. Also, during the 9-month follow-up, the number and size of stones in both groups decreased significantly (both: P<0.0001) in a way that the decrease in the intervention group showed no difference with the control group.Conclusions: Adjuvant treatment with zinc is not more effective than consecutive treatment in CHILDREN with NEPHROLITHIASIS. However, further studies are recommended due to the lack of clinical evidence in this field.

Cites

No record.

References

Cite

APA: Copy

YOUSEFICHAIJAN, PARSA, CYRUS, ALI, DORREH, FATEMEH, RAFEIE, MOHAMMAD, SHARAFKHAH, MOJTABA, FROHAR, FARYAR, & SAFI, FATEMEH. (2015). ORAL ZINC SULFATE AS ADJUVANT TREATMENT IN CHILDREN WITH NEPHROLITHIASIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL. IRANIAN JOURNAL OF PEDIATRICS, 25(6), 0-0. SID. https://sid.ir/paper/666791/en

Vancouver: Copy

YOUSEFICHAIJAN PARSA, CYRUS ALI, DORREH FATEMEH, RAFEIE MOHAMMAD, SHARAFKHAH MOJTABA, FROHAR FARYAR, SAFI FATEMEH. ORAL ZINC SULFATE AS ADJUVANT TREATMENT IN CHILDREN WITH NEPHROLITHIASIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2015;25(6):0-0. Available from: https://sid.ir/paper/666791/en

IEEE: Copy

PARSA YOUSEFICHAIJAN, ALI CYRUS, FATEMEH DORREH, MOHAMMAD RAFEIE, MOJTABA SHARAFKHAH, FARYAR FROHAR, and FATEMEH SAFI, “ORAL ZINC SULFATE AS ADJUVANT TREATMENT IN CHILDREN WITH NEPHROLITHIASIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL,” IRANIAN JOURNAL OF PEDIATRICS, vol. 25, no. 6, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/666791/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops